the applicant must provide a justification. it must show how the proposed research aligns with the priority areas of the strategy. 

the granting agencies recognize that some research proposals may overlap agency mandates. further, they recognize that some research may require an interdisciplinary approach. as such, the agencies are collaborating to ensure that areas of research that cross agency boundaries are eligible for support.

applicants should consult the guidelines of each agency to select the one best suited to consider their application.

for more information on how to apply and details on application deadlines please refer to the relevant scholarship details once they become available:

• sshrc postdoctoral fellowship application instructions
  (competition now open, deadline: september 16th, 8pm est)

six positions are available at idrc's head office in ottawa, canada.

this call is open to:

canadians or permanent residents of canada who are enrolled in a master’s or a doctoral degree at a recognized university or have completed (within the last three years) a master's or doctoral degree at a recognized university.

citizens of a developing country who are enrolled in a master’s or a doctoral degree at a canadian university or have completed (within the last three years) a master's or doctoral degree at a recognized university. in either case, applicants must already have a work permit valid for full-time work (37.5 hours per week) in canada until december 31, 2021 prior to applying.

please note: the expectation of receiving a post-graduation work permit is not sufficient.

additional eligibility requirements

• the proposed research must focus on one or more developing countries.
• these awards may be part of an academic requirement.
• the specific eligibility criteria of each research theme must be satisfied.

please note: successful award recipients cannot receive any other canadian government scholarship, award, subsidy, bursary, or honorarium, or hold any federal government contract in support of a research/work project for the duration of the award. this includes any other idrc award and any award managed by another institution but supported in whole or in part by idrc, such as the queen elizabeth advanced scholars program.

the specific objectives of this funding opportunity are:

1. how demographic change is altering the implicit contract between generations.
2. how policy can ensure that change results in a reduction, rather than an increase, in inequality.

the fy20 defense appropriations act provides funding to the department of defense pancreatic cancer research program (pcarp) to support a collaborative pancreatic cancer research paradigm that reduces the burden of pancreatic cancer.  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency j9, research and development directorate manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation.  the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp) at the u.s. army medical research and development command (usamrdc).

the fy20 pcarp program announcements and general application instructions for the following award mechanisms are posted on the grants.gov website. 

applications submitted to the fy20 pcarp must address one or more of the following focus areas:

• understanding precursors, origins, and early progression of pancreatic cancer
• understanding the events that promote pancreatic cancer metastasis 
• understanding the relationship between oncogenic signaling and the tumor microenvironment that drives drug resistance and therapeutic response
• integration of biologic and imaging biomarkers to drive more precise and earlier detection and prognosis
• defining viable tumor burden
• supportive care and patient-reported outcomes, quality of life, and perspectives during treatment and survivorship
• new drug development targeted toward cancer sensitivity and resistance mechanisms including immune mechanisms of resistance (for correlative studies only)
• development of pharmacological, immunological, or genetic interception approaches

https://cdmrp.army.mil/funding/pcarp

idea development award – preproposal due august 25, 2020

investigators at or above the level of assistant professor (or equivalent)

or

early-career investigator partnering principal investigator (pi) option: investigators at or above the level of assistant professor (or equivalent) may collaborate on a single application with a young investigator that meets the following criteria at the application submission deadline date:

• have completed at least 3 years of postdoctoral training or medical residency program
• is no more than 7 years from the receipt of a terminal degree
• can commit at least 50% protected time for the project
• preproposal is required; application submission is by invitation only.
• supports new ideas that represent innovative, high-risk/high-gain approaches to pancreatic cancer research and have the potential to make an important contribution to one or more of the fy20 pcarp focus areas.
• emphasis is equally placed on innovation and impact.
• preliminary data are encouraged, but not required.
• clinical trials are not allowed.
• must address at least one of the fy20 pcarp focus areas.

established single pi option:

• maximum funding of $500,000 for direct costs (plus indirect costs)
• maximum period of performance is 3 years

early-career investigator partnering pi option:

• maximum funding of $650,000 for direct costs (plus indirect costs)
• maximum period of performance is 3 years

translational research partnership award – preproposal due august 25, 2020

pis must be at or above the level of assistant professor or equivalent.

clinicians must be an m.d., m.d./ph.d., or equivalent with clinical duties and/or responsibilities.

• preproposal is required; application submission is by invitation only.
• supports partnerships between clinicians and laboratory scientists that accelerate ideas in pancreatic cancer into clinical applications.
• multi-institutional and multi-discipline partnerships are strongly encouraged. 
• must address at least one of the fy20 pcarp focus areas.
• supports translational correlative studies.
• preliminary data required.
• retrospective tissue analysis, correlative studies, or small pilot clinical studies are permitted.
• maximum funding of $750,000 for direct costs (plus indirect costs)
• maximum period of performance is 3 years

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final program announcements and general application instructions available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp and other usamrdc extramural funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org.  for more information about the pcarp or other cdmrp-administered programs, please visit the cdmrp website (https://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507
help@ebrap.org

insight grants are expected to respond to the objectives of the insight program.

insight grants support research excellence in the social sciences and humanities. funding is available to both emerging and established scholars for research initiatives of two to five years.

stable support for long-term research initiatives is central to advancing knowledge. it enables scholars to address complex issues about individuals and societies, and to further our collective understanding.

insight grants support research proposed by scholars and judged worthy of funding by their peers and/or other experts. insight grant research initiatives can be undertaken by an individual researcher or a team of researchers working in collaboration.

applicants choose from one of two streams, depending on the amount of funding required. both streams will be adjudicated by the same committees, and will receive the same rigorous level of merit review. the deadlines and application process are identical for both; however, the targeted success rate for stream a is higher than for stream b.

sshrc welcomes applications involving indigenous research, as well as those involving research-creation.

the goal of the exploration stream is to inspire high-risk, high-reward and interdisciplinary research.

exploration grants support research that pushes boundaries into exciting new areas. researchers are encouraged to think “outside of the box,” undertake research that would defy current paradigms, and bring disciplines together in unexpected ways and from bold, innovative perspectives. with the exploration stream, there is recognition that innovation often carries risk; proposals for high-risk research projects that have the potential to deliver game-changing impacts are strongly encouraged.

exploration stream grants support projects that:

• bring disciplines together beyond traditional disciplinary or common interdisciplinary approaches;
• propose to explore something new, which might fail; and
• have the potential for significant impact.

exploration grants support research with a range of impacts, some of which might be social, cultural, economic, health-related or technological. this list is not exhaustive; other types of impacts are also recognized. diversity of perspectives is important, and the fund encourages research proposals led from any discipline, from those in the social sciences and humanities, to health, the natural sciences and engineering.

to better promote ground-breaking and interdisciplinary research, the new frontiers in research fund (nfrf) has a mandate to explore innovative merit review processes, and the flexibility for competition parameters and processes to evolve from one competition to the next. the 2020 exploration competition merit review processes differ from those of previous exploration competitions, and include elements distinct from those used in flagship tri-agency programs.

the fy20 defense appropriations act provides funding to the department of defense chronic pain management research program (cpmrp) to support research of exceptional scientific merit with the potential to make a significant impact on improving the health and quality of life of service members, veterans, and all americans living with chronic pain.  per the fy19 cpmrp congressional appropriation, chronic pain is defined as a pain that occurs on at least half the days for six months or more, and which can be caused by issues including, but not limited to:  combat- and training-related physical or mental stress and trauma, migraines and chronic headaches, traumatic brain injury, arthritis, muscular-skeletal conditions, neurological disease, tick and vector-borne disease, other insect-transmitted or tropical disease, and cancer.  the cpmrp seeks to support and promote innovative, high-impact research to prevent the development and improve the management of chronic pain, with specific emphasis on the utilization and implementation of non-opioid therapies or non-addictive complementary methods.  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency j9, research and development directorate manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation.  the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp) at the u.s. army medical research and development command (usamrdc).

the fy20 cpmrp program announcements and general application instructions for the following award mechanisms are posted on the grants.gov website 

applications submitted to the fy20 cpmrp award mechanisms must address one or more of the fy20 cpmrp focus areas.

• investigator-initiated research award
  • chronification of pain (i.e., the acute-to-chronic pain transition)
  • development of novel non-µ-opioid receptor targeted therapies for the treatment of chronic pain
• translational research award
  • comparative effectiveness (for evidence-based, efficacious interventions to manage chronic pain)
  • implementation science (for evidence-based, efficacious interventions to manage chronic pain)

https://cdmrp.army.mil/funding/cpmrp

investigator-initiated research award – preproposal due august 7, 2020

investigators at or above the level of assistant professor (or equivalent)

• supports innovative research that will make an original and important contribution to the field of research, patient care, and/or quality of life in one of the fy20 cpmrp iira focus areas of chronification of pain and development of non-u-opioid receptor-targeted therapies and approaches.
• multidisciplinary collaborations and innovative approaches are encouraged.
• clinical trials will not funded.
• pre-application submission is required; application submission is by invitation only.
• the maximum allowable funding for the entire period of performance is $900,000 for direct costs
• indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
• the maximum period of performance is 4 years

translational research award – preproposal due august 7, 2020

investigators at or above the level of assistant professor (or equivalent)

• supports translational research that will accelerate the movement of efficacious, evidence-based ideas into clinical applications.
• research must address one or both of the fy20 cpmrp tra focus areas of implementation science and comparative effectiveness.
• effectiveness-implementation hybrid studies that incorporate biopsychosocial models of assessment are encouraged.
• studies seeking to evaluate new therapies or approaches, either pharmacological or non-pharmacological, that have not been previously evaluated in a clinical setting will not be funded.
• pre-application submission is required; application submission is by invitation only.
• the maximum allowable funding for the entire period of performance is $1,400,000 for direct costs
• indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
• the maximum period of performance is 4 years

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final program announcements and general application instructions available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp and other usamrdc extramural funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org.  for more information about the cpmrp or other cdmrp-administered programs, please visit the cdmrp website (https://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507
help@ebrap.org